Evidence map›Paper›PMID 28981078›Full record

ArticleJournal of perinatology : official journal of the California Perinatal Association2017

Maternal magnesium therapy, neonatal serum magnesium concentration and immediate neonatal outcomes.

D Narasimhulu, A Brown, N M Egbert, M Rojas, S Haberman, A Bhutada, H Minkoff, S Rastogi

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of perinatology : official journal of the California Perinatal Association, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Antenatal Magnesium Sulfate and adverse gastrointestinal outcomes in Preterm infants-a systematic review and meta-analysis.Journal of perinatology : official journal of the California Perinatal Association · 2023
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

D NarasimhuluDepartment of Obstetrics and Gynecology, Maimonides Medical Center, Albert Einstein College of Medicine, Brooklyn, NY, USA.
A BrownDepartment of Pediatrics, Maimonides Medical Center, Albert Einstein College of Medicine, Brooklyn, NY, USA.
N M EgbertDepartment of Obstetrics and Gynecology, Maimonides Medical Center, Albert Einstein College of Medicine, Brooklyn, NY, USA.
M RojasDepartment of Pediatrics, Maimonides Medical Center, Albert Einstein College of Medicine, Brooklyn, NY, USA.ORCID 0000-0002-0542-4270
S HabermanDepartment of Obstetrics and Gynecology, Maimonides Medical Center, Albert Einstein College of Medicine, Brooklyn, NY, USA.
A BhutadaDepartment of Pediatrics, Maimonides Medical Center, Albert Einstein College of Medicine, Brooklyn, NY, USA.
H MinkoffDepartment of Obstetrics and Gynecology, Maimonides Medical Center, Albert Einstein College of Medicine, Brooklyn, NY, USA.
S RastogiDepartment of Pediatrics, Maimonides Medical Center, Albert Einstein College of Medicine, Brooklyn, NY, USA.
Maimonides Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe fetus is exposed to magnesium administered to the pregnant mother. However, there is controversy regarding magnesium-related neonatal adverse outcomes, largely driven by a limited understanding of the factors that influence neonatal serum magnesium concentrations and associated outcomes. The objective of this study was to examine the relationship between antenatal maternal magnesium dose and serum concentrations, neonatal serum magnesium concentration and immediate neonatal outcomes. STUDY

designA retrospective study was conducted at a community-based teaching hospital. Neonatal serum magnesium concentrations within 48 h of birth were used to stratify magnesium-exposed neonates into three groups: group 1: <2.5 mg dl

resultsOf the 304 mother-baby dyads between 24 and 34 weeks gestation, 237 received antenatal magnesium. Neonatal serum magnesium concentration was 3.14±0.83 mg dl

conclusionThe between-group differences highlight that there is a therapeutic range of neonatal serum magnesium concentrations for neuroprotective effects of antenatal magnesium sulfate, while concentrations outside of this range may be associated with adverse neonatal outcomes. Further studies are needed to determine the optimal dose and duration of maternal magnesium to minimize adverse neonatal outcomes.

Indexed as

AdultCase-Control StudiesCerebral Intraventricular HemorrhageDose-Response Relationship, DrugFemaleGestational AgeHumansInfant, NewbornInfant, Newborn, DiseasesInfusions, IntravenousLeukomalacia, PeriventricularMagnesiumMagnesium SulfateMaleNeuroprotective AgentsPregnancyMagnesiumMagnesium SulfateNeuroprotective AgentsTocolytic Agents

Identifiers

PMID28981078
OpenAlexW2762064651

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.